Literature DB >> 29377225

Pathogenic mechanisms of invasive group A Streptococcus infections by influenza virus-group A Streptococcus superinfection.

Shigefumi Okamoto1,2, Satoshi Nagase1.   

Abstract

Group A Streptococcus (GAS) are pathogenic bacteria of the genus Streptococcus and cause severe invasive infections that comprise a wide range of diverse diseases, including acute respiratory distress syndrome, renal failure, toxic shock-like syndrome, sepsis, cellulitis and necrotizing fasciitis. The essential virulence, infected host and external environmental factors required for invasive GAS infections have not yet been determined. Superinfection with influenza virus and GAS induced invasive GAS infections was demonstrated by our team in a mouse model, after which clinical cases of invasive GAS infections secondary to influenza virus infection were reported by other investigators in Japan, USA, Canada, UK China, and other countries. However, the pathogenic mechanisms underlying influenza virus-GAS superinfection are not yet fully understood. The present review describes the current knowledge about invasive GAS infections by superinfection. Topics addressed include the bacteriological, virological and immunological mechanisms impacting invasion upon superinfection on top of underlying influenza virus infection by GAS and other bacteria (i.e., Streptococcus pneumoniae and Staphylococcus aureus). Future prospects are also discussed.
© 2018 The Societies and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  group A Streptococcus (GAS); influenza virus; invasive GAS infections; superinfection

Mesh:

Substances:

Year:  2018        PMID: 29377225     DOI: 10.1111/1348-0421.12577

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  6 in total

1.  Contributions of Influenza Virus Hemagglutinin and Host Immune Responses Toward the Severity of Influenza Virus: Streptococcus pyogenes Superinfections.

Authors:  Joshua M Klonoski; Trevor Watson; Thomas E Bickett; Joshua M Svendsen; Tonia J Gau; Alexandra Britt; Jeff T Nelson; Evelyn H Schlenker; Michael S Chaussee; Agnieszka Rynda-Apple; Victor C Huber
Journal:  Viral Immunol       Date:  2018-06-05       Impact factor: 2.257

Review 2.  Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis.

Authors:  Anjali A Satoskar; Samir V Parikh; Tibor Nadasdy
Journal:  Nat Rev Nephrol       Date:  2019-08-09       Impact factor: 28.314

3.  Immunotherapy targeting the Streptococcus pyogenes M protein or streptolysin O to treat or prevent influenza A superinfection.

Authors:  Andrea L Herrera; Christopher Van Hove; Mary Hanson; James B Dale; Rodney K Tweten; Victor C Huber; Diego Diel; Michael S Chaussee
Journal:  PLoS One       Date:  2020-06-23       Impact factor: 3.240

4.  A dynamically evolving war between autophagy and pathogenic microorganisms.

Authors:  Qianqian Zheng; Liangwei Duan; Yang Zhang; Jiaoyang Li; Shiyu Zhang; Hui Wang
Journal:  J Zhejiang Univ Sci B       Date:  2022-01-15       Impact factor: 3.066

5.  Invasive group A Streptococcus disease in Australian children: 2016 to 2018 - a descriptive cohort study.

Authors:  Jane Oliver; Elise Thielemans; Alissa McMinn; Ciara Baker; Philip N Britton; Julia E Clark; Helen S Marshall; Christopher C Blyth; Joshua Francis; Jim Buttery; Andrew C Steer; Nigel W Crawford
Journal:  BMC Public Health       Date:  2019-12-30       Impact factor: 3.295

6.  Pneumatocele formation in a fatal adult pneumonia patient coinfected with Streptococcus pyogenes emm-type 3 and influenza A: a case report.

Authors:  Masahiro Sano; Aya Shimamoto; Nozomi Ueki; Motohiro Sekino; Hiroshi Nakaoka; Masahiro Takaki; Yoshiro Yamashita; Takeshi Tanaka; Konosuke Morimoto; Katsunori Yanagihara; Masahiro Nakashima; Kazuto Ashizawa; Koya Ariyoshi
Journal:  BMC Infect Dis       Date:  2020-11-26       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.